Rubius Therapeutics

+$0.03 (+2.97%) Today
$0.00 (0.00%) As of 8:44 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RUBY and other ETFs, options, and stocks.

About RUBY

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.

CEO
Pablo J. Cagnoni
Employees
269
Headquarters
Cambridge, Massachusetts
Founded
2013

RUBY Key Statistics

Market cap
93.82M
Price-Earnings ratio
—
Dividend yield
—
Average volume
899.52K
High today
$1.04
Low today
$0.9034
Open price
$1.02
Volume
1.16M
52 Week high
$29.06
52 Week low
$0.9034

RUBY Earnings

-$0.61
-$0.57
-$0.53
-$0.49
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.58 per share
Actual
-$0.58 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure